ID,MEDICATION,GENE(S),PRESCRIBING CONSIDERATIONS BASED ON myDNA TEST,INTERACTION
L65-291,Codeine (component of Acetaminophen-Caffeine-Codeine),"CYP2D6OPRM1",Usual prescribing considerations apply,NA
L65-291,Nortriptyline,CYP2D6,Usual prescribing considerations apply,INCREASED RISK OF SEROTONIN TOXICITY WITH SERTRALINE AND LITHIUM
L65-291,Quetiapine,CYP3A4,Usual prescribing considerations apply,NA
L65-291,Sertraline,CYP2C19,Usual prescribing considerations apply,INCREASED RISK OF SEROTONIN TOXICITY WITH NORTRIPTYLINE AND LITHIUM
L65-291,zopiclone,NA,NO,NA
L65-291, clonazepam (Rivotril),NA,NO,NA
L65-291, betamethasone dipropionate,NA,NO,NA
L65-291, lithium,NA,NO,INCREASED RISK OF SEROTONIN TOXICITY WITH SERTRALINE AND NORTRIPTYLINE
L65-291, acetaminophen (component of Acetaminophen-Caffeine-Codeine),NA,NO,NA
L65-291, caffeine (component of Acetaminophen-Caffeine-Codeine),NA,NO,NA
